Abstract:For systemic medicinal products bioavailability is a fundamental characteristic that determines their efficacy and onset of action. Biopharmaceutical parameters of nasal preparations (physicochemical properties of the active substance such as membrane permeability, solubility, lipophilicity, pKa, polymorphic state, type of finished dosage form, pH, osmolarity, composition and characteristics of excipients), affecting bioavailability, are variable and controllable within pharmaceutical development. Besides the use of components that affect enzymatic activity, mucoadhesion and effective con-tact time, mucociliary clearance and viscosity of mucous secretion, changing the rate and degree of absorption of the active substance is possible by modulation of tight junctions and paracellular transport. These processes can be particularly determined by the osmolarity of the dosage form and the use of permeation enhancers. Taking into account the portfolio of excipients available to scientists used in a wide range of concentrations, and, in addi-tion, the requirements of the target product profile in terms of safety and pharmacokinetic parameters, as well as regulatory recommendations for jus-tification of the composition within pharmaceutical development, with particular emphasis on the selection of functional components and the concen-trations used, it is important to have relevant and reliable screening tools when formulating a drug product. Due to the absence of standard bioavailabil-ity assessment methods for nasal preparations, literature review was conducted and methodology of in vitro permeability study for of nasal medicinal products for systemic action with the use of artificial membranes as well as cell line RPMI 2650 of human nasal epithelium is developed. The use of such sufficiently homogeneous barrier films allows to minimize the variability of test conditions. Permeation study of developed compositions of an-timigraine medicinal product is conducted. The results obtained provide evidence of their qualitative compliance and allow to recommend laboratory permeability study on cellulose membranes for the selection and justification of the composition of pharmaceutical compositions. Bioavailability is a fundamental characteristic of pharmaceutical products for systemic action, which defines efficacy and speed of action. Permeability through biological membranes is defined not only by the properties of active component but also by the particulars of formulation. Due to the absence of standard bioavailability assessment methods for nasal preparations, literature review was conducted and methodology of in vitro permeability study for of nasal medicinal products for systemic action with the use of artificial membranes as well as cell line RPMI 2650 is developed. Permeation study of developed compositions of antimigraine medicinal product is conducted. The results obtained provide evidence of their qualitative compliance and allow to recommend laboratory permeability study on cellulose membranes as a screening tool in pharmaceutical development.

In Vitro-in situ Correlation of Propafenone Transnasal Absorption

[Studies on Octanol-Water Partition Coefficient and Nasal Drug Absorption].

[Study on Nasal Absorption of Cistanche Deserticola Phenylethanol Glycosides Nanoemulsion in Vivo].

In Vitro Digestion-In Situ Absorption Setup Employing a Physiologically Relevant Value of the Membrane Surface Area/Volume Ratio for Evaluating Performance of Lipid-Based Formulations: A Comparative Study with an In Vitro Digestion-Permeation Model

Correlation Evaluation of Transdermal Delivery in Vitro and in Vivo with Zhibitong Cataplasm

Determination of S-propargylcysteine by HPLC and Its in Situ Intestine Absorption in Rats

Study on Correlation Between Dissolution in Vitro and Absorption in Vivo of Nimodipine Tablets

Kinetic model to predict the absorption of nasally applied drugs from in vitro transcellular permeability of drugs

Influence of in Vitro Methods, Receptor Fluids on Percutaneous Absorption and Validation of a Novel in Vitro Method.

Performance and toxicity of different absorption enhancers used in the preparation of Poloxamer thermosensitive in situ gels for ketamine nasal administration

Prediction of Human Absorption of Natural Compounds by the Non-Everted Rat Intestinal Sac Model

Comparison of Modern In Vitro Permeability Methods with the Aim of Investigation Nasal Dosage Forms

Influence of pH Environment on Nasal Absorption of Meptazinol Hydrochloride

Study on the Release of Fenofibrate Nanosuspensionin Vitroand Its Correlation Within Situintestinal Andin Vivoabsorption Kinetics in Rats

Validation of an Ex Vivo Permeation Method for the Intestinal Permeability of Different BCS Drugs and Its Correlation with Caco-2 In Vitro Experiments

IN VITRO PERMEABILITY STUDY OF NASAL MEDICINAL PRODUCT FOR SYSTEMIC ACTION

Pharmacokinetic and pharmacodynamic study of Panax notoginseng saponins nasal gel spray

Preparation and Percutaneous Absorption in Vitro of Ruanganxiaoshui Cataplasma

A Method for Evaluating Drug Penetration and Absorption Through Isolated Buccal Mucosa with Highly Accuracy and Reproducibility

Study on In Vitro-In Vivo Correlation of Naftopidil Sustained-release Capsules

Comparisons of in Vitro Fick’s First Law, Lipolysis, and in Vivo Rat Models for Oral Absorption on BCS II Drugs in SNEDDS